ACTUALIDAD

A Double-Masked, Randomised, Placebo-Controlled, Parallel-Group, 12-Week, Phase 2 Study to Investigate the Safety and Efficacy of Ripasudil (K-321) Eye Drops After Descemetorhexis in Patients with Fuchs Endothelial Corneal Dystrophy

 

INVESTIGADOR:

Dr. José F. Alfonso Sánchez
 FINALIZADO 

 

A Double-Masked, Randomised, Placebo-Controlled, Parallel-Group, 12-Week, Phase 2 Study to Investigate the Safety and Efficacy of Ripasudil (K-321) Eye Drops After Descemetorhexis in Patients with Fuchs Endothelial Corneal Dystrophy


PATOLOGÍA: Distrofia de Fuchs
TRATAMIENTO: Ripasudil
CÓDIGO DE ESTUDIO: K-321-201
PROMOTOR: Kowa Research Institute
Déjanos tus datos
Nos pondremos en contacto contigo
Por favor, activa JavaScript en tu navegador para completar este formulario.
Casillas de verificación